Comprehensive HRMS Screening and Risk Assessments of Aristolochic Acid Analogues in Asari Radix et Rhizoma and Related Commercial Health Products-Reference-Cited by-同舟云学术

Comprehensive HRMS Screening and Risk Assessments of Aristolochic Acid Analogues in Asari Radix et Rhizoma and Related Commercial Health Products

Published:2024-03-21 Issue:13 Volume:72 Page:7438-7456
ISSN:0021-8561
Container-title:Journal of Agricultural and Food Chemistry
language:en
Short-container-title:J. Agric. Food Chem.

Author:

Hu Yun-shu¹²,Zhang Jian-qing²,Wei Wen-long²,Yang Huan-ya¹,Sha Fei²,Shen Xuan-jing²,Yao Shuai²,Li Jia-yuan²,Qu Hua²,Li Ping³,Chen Xiang-mei³,Guo Dean¹²^ORCID

Affiliation:

1. School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu China

2. National Engineering Research Center of TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Haike Road #501, Shanghai 201203, China

3. National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing 100853, China

Funder

Science and Technology Major Project of Inner Mongolia

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jafc.4c00751

Reference51 articles.

1. Naturally occurring aristolochic acid analogues and their toxicities

2. Aristolochic Acid Nephropathy: Epidemiology, Clinical Presentation, and Treatment

3. Nephrotoxicity induced by natural compounds from herbal medicines – a challenge for clinical application

4. Herbal products containing aristolochic acids: A call to revisit the context of safety

5. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy